Ms. Tracy Valorie serves as Senior Vice President and General Manager of US Pharmaceuticals at Bausch & Lomb Incorporated. Ms. Valorie has almost three decades of experience in the pharmaceutical industry. Ms. Valorie has held a number of roles with increasing responsibility in discovery science, clinical development, early commercial assessment, marketing and strategic planning. Since joining Bausch + Lomb in 2013, she has led a strong team of cross-functional employees dedicated to the company's Pharmaceutical product portfolio with an emphasis on identifying growth opportunities in the business. This includes adding novel technologies to the portfolio through exclusive licensing agreements with EyeGate Pharmaceuticals and expanding the portfolio's glaucoma franchise with the company's current glaucoma candidate, latanoprostene bunod. Prior to joining Bausch + Lomb, Ms. Valorie was the commercial lead of Ophthalmology at Pfizer overseeing the company's global ophthalmology brands as well as commercial development of the mid-stage portfolio and long-range strategic planning.

clinical development